The Company is comprised of two operating groups. The Acacia Technologies group develops, acquires, and licenses patented technologies. The CombiMatrix group is seeking to become a diversified biotechnology business.


Updates from The Motley Fool

Latest updates on CombiMatrix from Fool.com.


Stock Performance

CBMX vs. S&P 500 | 2 Year Performance
View Interactive CBMX Charts
Sponsored by

Key Data Points

Primary metrics and data points about CombiMatrix.
Current Price: $2.78
Prev Close: $2.78
Open: $2.75
Bid: $2.73
Ask: $2.80
Day's Range: $2.73 - $2.81
52wk Range: $2.62 - $19.05
Volume: 11,858
Avg Vol 65,940
Market Cap: $35.19M
P/E (ttm): -0.37
EPS (ttm): -$7.51
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about CombiMatrix.
CAPS Rating 0 out of 5
 
2 Outperform
0 Underperform
CAPS All Stars
 
0 Outperform
0 Underperform

How do you think CombiMatrix will perform against the market?



You pick for CombiMatrix is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for CombiMatrix.

The Company is comprised of two operating groups. The Acacia Technologies group develops, acquires, and licenses patented technologies. The CombiMatrix group is seeking to become a diversified biotechnology business.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT